These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32299374)

  • 1. Mapping lymphatic filariasis in Loa loa endemic health districts naïve for ivermectin mass administration and situated in the forested zone of Cameroon.
    Beng AA; Esum ME; Deribe K; Njouendou AJ; Ndongmo PWC; Abong RA; Fru J; Fombad FF; Nchanji GT; Amambo G; Gandjui NTV; Biholong B; Nko'Ayissi G; Mbia P; Akame J; Enyong PI; Reid SD; Tougoue JJ; Zhang Y; Wanji S
    BMC Infect Dis; 2020 Apr; 20(1):284. PubMed ID: 32299374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-Reactivity of Filariais ICT Cards in Areas of Contrasting Endemicity of Loa loa and Mansonella perstans in Cameroon: Implications for Shrinking of the Lymphatic Filariasis Map in the Central African Region.
    Wanji S; Amvongo-Adjia N; Koudou B; Njouendou AJ; Chounna Ndongmo PW; Kengne-Ouafo JA; Datchoua-Poutcheu FR; Fovennso BA; Tayong DB; Fombad FF; Fischer PU; Enyong PI; Bockarie M
    PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004184. PubMed ID: 26544042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of lymphatic filariasis in loiasis areas: A new strategy shows no evidence for Wuchereria bancrofti endemicity in Cameroon.
    Wanji S; Esum ME; Njouendou AJ; Mbeng AA; Chounna Ndongmo PW; Abong RA; Fru J; Fombad FF; Nchanji GT; Ngongeh G; Ngandjui NV; Enyong PI; Storey H; Curtis KC; Fischer K; Fauver JR; Lew D; Goss CW; Fischer PU
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007192. PubMed ID: 30849120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positivity of Antigen Tests Used for Diagnosis of Lymphatic Filariasis in Individuals Without Wuchereria bancrofti Infection But with High Loa loa Microfilaremia.
    Pion SD; Montavon C; Chesnais CB; Kamgno J; Wanji S; Klion AD; Nutman TB; Boussinesq M
    Am J Trop Med Hyg; 2016 Dec; 95(6):1417-1423. PubMed ID: 27729568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low transmission of Wuchereria bancrofti in cross-border districts of Côte d'Ivoire: A great step towards lymphatic filariasis elimination in West Africa.
    Yokoly FN; Zahouli JBZ; Méite A; Opoku M; Kouassi BL; de Souza DK; Bockarie M; Koudou BG
    PLoS One; 2020; 15(4):e0231541. PubMed ID: 32282840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of Loa loa antigens responsible for cross-reactivity with rapid diagnostic tests for lymphatic filariasis.
    Hertz MI; Nana-Djeunga H; Kamgno J; Jelil Njouendou A; Chawa Chunda V; Wanji S; Rush A; Fischer PU; Weil GJ; Budge PJ
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006963. PubMed ID: 30444866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic filariasis mapping by immunochromatographic test cards and baseline microfilaria survey prior to mass drug administration in Sierra Leone.
    Koroma JB; Bangura MM; Hodges MH; Bah MS; Zhang Y; Bockarie MJ
    Parasit Vectors; 2012 Jan; 5():10. PubMed ID: 22236419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of sensitivity of immunochromatographic test (ICT) for lymphatic filariasis diagnosis in low prevalence settings: consequence in the monitoring and evaluation procedures.
    Gounoue-Kamkumo R; Nana-Djeunga HC; Bopda J; Akame J; Tarini A; Kamgno J
    BMC Infect Dis; 2015 Dec; 15():579. PubMed ID: 26700472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration.
    Jones C; Ngasala B; Derua YA; Tarimo D; Reimer L; Bockarie M; Malecela MN
    Parasit Vectors; 2018 Nov; 11(1):588. PubMed ID: 30424781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evidence of the cross-reactivity of the Binax NOW® Filariasis ICT cards to non-Wuchereria bancrofti filariae: experimental studies with Loa loa and Onchocerca ochengi.
    Wanji S; Amvongo-Adjia N; Njouendou AJ; Kengne-Ouafo JA; Ndongmo WP; Fombad FF; Koudou B; Enyong PA; Bockarie M
    Parasit Vectors; 2016 May; 9():267. PubMed ID: 27151313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing evidence of low lymphatic filariasis prevalence in high risk Loa loa areas in Central and West Africa: a literature review.
    Kelly-Hope LA; Hemingway J; Taylor MJ; Molyneux DH
    Parasit Vectors; 2018 Jun; 11(1):349. PubMed ID: 29907117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania.
    Lupenza ET; Gasarasi DB; Minzi OM
    PLoS One; 2022; 17(1):e0262693. PubMed ID: 35045109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-center field study of two point-of-care tests for circulating Wuchereria bancrofti antigenemia in Africa.
    Chesnais CB; Awaca-Uvon NP; Bolay FK; Boussinesq M; Fischer PU; Gankpala L; Meite A; Missamou F; Pion SD; Weil GJ
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005703. PubMed ID: 28892473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Filarial antigenemia and Loa loa night blood microfilaremia in an area without bancroftian filariasis in the Democratic Republic of Congo.
    Bakajika DK; Nigo MM; Lotsima JP; Masikini GA; Fischer K; Lloyd MM; Weil GJ; Fischer PU
    Am J Trop Med Hyg; 2014 Dec; 91(6):1142-1148. PubMed ID: 25223938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.
    Endeshaw T; Taye A; Tadesse Z; Katabarwa MN; Shafi O; Seid T; Richards FO
    Pathog Glob Health; 2015; 109(7):344-51. PubMed ID: 26878935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
    Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo].
    Dorkenoo AM; Sodahlon YK; Bronzan RN; Yakpa K; Sossou E; Ouro-Medeli A; Teko M; Seim A; Mathieu E
    Bull Soc Pathol Exot; 2015 Aug; 108(3):181-7. PubMed ID: 25476256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
    Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the geographical distribution of podoconiosis in Cameroon using parasitological, serological, and clinical evidence to exclude other causes of lymphedema.
    Deribe K; Beng AA; Cano J; Njouendo AJ; Fru-Cho J; Awah AR; Eyong ME; Chounna Ndongmo PW; Giorgi E; Pigott DM; Golding N; Pullan RL; Noor AM; Enquselassie F; Murray CJL; Brooker SJ; Hay SI; Enyong P; Newport MJ; Wanji S; Davey G
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006126. PubMed ID: 29324858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.